ApoE Îµ4 Status,Percentage of Patients,Incidence of ARIA (LEQEMBI),Incidence of ARIA (Placebo),Incidence of Symptomatic ARIA-E (LEQEMBI)
Homozygotes (141/898),16%,45%,22%,9%
Heterozygotes (479/898),53%,19%,9%,2%
Noncarriers (278/898),31%,13%,4%,1%
